1430563-87-3 Usage
Uses
Used in Pharmaceutical Industry:
Tert-butyl 1-(4-carbamoylphenylcarbamoyl)-5-(pyridin-2-yloxy)-3,4-dihydroisoquinoline-2(1H)-carboxylate is used as a potential pharmaceutical agent for its ability to interact with biological targets due to the presence of carbamoyl and pyridin-2-yloxy groups. Its complex structure may offer unique binding properties and therapeutic effects, which require further research to elucidate its full potential in drug development.
Used in Organic Synthesis:
In the field of organic synthesis, tert-butyl 1-(4-carbamoylphenylcarbamoyl)-5-(pyridin-2-yloxy)-3,4-dihydroisoquinoline-2(1H)-carboxylate serves as a key intermediate or building block in the synthesis of more complex organic molecules. Its versatile functional groups can be further modified or used in reactions to create a variety of compounds with different properties and applications.
Used in Materials Science:
Tert-butyl 1-(4-carbamoylphenylcarbamoyl)-5-(pyridin-2-yloxy)-3,4-dihydroisoquinoline-2(1H)-carboxylate may also find applications in materials science, where its unique molecular structure could contribute to the development of new materials with specific properties. tert-butyl 1-(4-carbamoylphenylcarbamoyl)-5-(pyridin-2-yloxy)-3,4-dihydroisoquinoline-2(1H)-carboxylate's potential to form interactions with other molecules or surfaces could be harnessed for creating materials with tailored characteristics for various applications.
Check Digit Verification of cas no
The CAS Registry Mumber 1430563-87-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,4,3,0,5,6 and 3 respectively; the second part has 2 digits, 8 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1430563-87:
(9*1)+(8*4)+(7*3)+(6*0)+(5*5)+(4*6)+(3*3)+(2*8)+(1*7)=143
143 % 10 = 3
So 1430563-87-3 is a valid CAS Registry Number.
1430563-87-3Relevant academic research and scientific papers
SUBSTITUTED TETRAHYDROISOQUINOLINE COMPOUNDS AS FACTOR XIA INHIBITORS
-
, (2013/04/25)
The present invention provides compounds of Formula (I) or stereoisomers, pharmaceutically acceptable salts thereof, wherein all of the variables are as defined herein. These compounds are inhibitors of factor XIa and/or plasma kallikrein which may be used as medicaments.
